<DOC>
	<DOCNO>NCT01125033</DOCNO>
	<brief_summary>The purpose study determine whether vitamin C , vitamin E combination effective treatment RLS hemodialysis patient .</brief_summary>
	<brief_title>Study Vitamin C , Vitamin E Their Combination Treat Restless Legs Syndrome Hemodialysis Patients</brief_title>
	<detailed_description>RLS common problem hemodialysis patient ; 20 40 % hemodialysis patient suffer RLS . Hemodialysis patient high oxidative stress status . Oxidative stress propose play important role pathogenesis RLS . Vitamin C vitamin E potent antioxidant agent already show effective treatment periodic limb movement disorder ( PLMD ) hemodialysis patient . PLMD closely associate RLS hemodialysis patient . The aim study evaluate efficacy vitamin C , vitamin E combination treatment RLS hemodialysis patient .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>Patients fulfill Restless leg syndrome international criterion ( IRLSSG ) Patients stable HD without internment illness admission Patients renal stone Patients receive medication RLS aggravate alleviate property</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Dialysis , Restless legs syndrome , Ascorbic acid , Vitamin E</keyword>
</DOC>